Selected research
Market Structure
Global ChIP Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global ChIP Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for ChIP Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for ChIP Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for ChIP Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for ChIP Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of ChIP Sequencing include Illumina, BGI, Creative Biolabs, Thermo Fisher Scientific, Eurofins Genomics, Diagenode, Merck, Agilent and Zymo Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global ChIP Sequencing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of ChIP Sequencing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents ChIP Sequencing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the ChIP Sequencing market size, projected growth trends, production technologies, key applications, and end-use industries.
ChIP Sequencing Segment by Company
Illumina
BGI
Creative Biolabs
Thermo Fisher Scientific
Eurofins Genomics
Diagenode
Merck
Agilent
Zymo Research
Chromatrap
Active Motif
ChIP Sequencing Segment by Type
Consumables and Reagents
Service
Other
ChIP Sequencing Segment by Application
Consumables and Reagents
Service
Other
ChIP Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ChIP Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ChIP Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ChIP Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of ChIP Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global ChIP Sequencing industry.
Chapter 3: Detailed analysis of ChIP Sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ChIP Sequencingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Consumables and Reagents
- Service
- Other
Applications
- Consumables and Reagents
- Service
- Other
Companies covered
- Illumina
- BGI
- Creative Biolabs
- Thermo Fisher Scientific
- Eurofins Genomics
- Diagenode
- Merck
- Agilent
- Zymo Research
- Chromatrap
- Active Motif
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global ChIP Sequencing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Consumables and Reagents
- 1.2.3 Service
- 1.2.4 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global ChIP Sequencing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Consumables and Reagents
- 1.3.3 Service
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global ChIP Sequencing Growth Trends by Region
- 1.5.1 Global ChIP Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 ChIP Sequencing Market Size by Region (2021-2026)
- 1.5.3 ChIP Sequencing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global ChIP Sequencing Market Dynamics
- 2.1 ChIP Sequencing Industry Trends
- 2.2 ChIP Sequencing Industry Drivers
- 2.3 ChIP Sequencing Industry Opportunities and Challenges
- 2.4 ChIP Sequencing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global ChIP Sequencing Revenue by Company (2021-2026)
- 3.2 Global ChIP Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global ChIP Sequencing Key Company Head office and Area Served
- 3.4 Global ChIP Sequencing Company, Product Type & Application
- 3.5 Global ChIP Sequencing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global ChIP Sequencing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 ChIP Sequencing Players Market Share by Revenue in 2025
- 3.6.3 2025 ChIP Sequencing Tier 1, Tier 2, and Tier 3
4 ChIP Sequencing Market by Type
- 4.1 Global ChIP Sequencing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global ChIP Sequencing Market Size by Type (2021-2032)
- 4.3 Global ChIP Sequencing Market Size Share by Type (2021-2032)
5 ChIP Sequencing Market by Application
- 5.1 Global ChIP Sequencing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global ChIP Sequencing Market Size by Application (2021-2032)
- 5.3 Global ChIP Sequencing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Illumina ChIP Sequencing Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 BGI
- 6.2.1 BGI Company Information
- 6.2.2 BGI Business Overview
- 6.2.3 BGI ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BGI ChIP Sequencing Product Portfolio
- 6.2.5 BGI Recent Developments
- 6.3 Creative Biolabs
- 6.3.1 Creative Biolabs Company Information
- 6.3.2 Creative Biolabs Business Overview
- 6.3.3 Creative Biolabs ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Creative Biolabs ChIP Sequencing Product Portfolio
- 6.3.5 Creative Biolabs Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Thermo Fisher Scientific ChIP Sequencing Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 Eurofins Genomics
- 6.5.1 Eurofins Genomics Company Information
- 6.5.2 Eurofins Genomics Business Overview
- 6.5.3 Eurofins Genomics ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Eurofins Genomics ChIP Sequencing Product Portfolio
- 6.5.5 Eurofins Genomics Recent Developments
- 6.6 Diagenode
- 6.6.1 Diagenode Company Information
- 6.6.2 Diagenode Business Overview
- 6.6.3 Diagenode ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Diagenode ChIP Sequencing Product Portfolio
- 6.6.5 Diagenode Recent Developments
- 6.7 Merck
- 6.7.1 Merck Company Information
- 6.7.2 Merck Business Overview
- 6.7.3 Merck ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Merck ChIP Sequencing Product Portfolio
- 6.7.5 Merck Recent Developments
- 6.8 Agilent
- 6.8.1 Agilent Company Information
- 6.8.2 Agilent Business Overview
- 6.8.3 Agilent ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Agilent ChIP Sequencing Product Portfolio
- 6.8.5 Agilent Recent Developments
- 6.9 Zymo Research
- 6.9.1 Zymo Research Company Information
- 6.9.2 Zymo Research Business Overview
- 6.9.3 Zymo Research ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Zymo Research ChIP Sequencing Product Portfolio
- 6.9.5 Zymo Research Recent Developments
- 6.10 Chromatrap
- 6.10.1 Chromatrap Company Information
- 6.10.2 Chromatrap Business Overview
- 6.10.3 Chromatrap ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Chromatrap ChIP Sequencing Product Portfolio
- 6.10.5 Chromatrap Recent Developments
- 6.11 Active Motif
- 6.11.1 Active Motif Company Information
- 6.11.2 Active Motif Business Overview
- 6.11.3 Active Motif ChIP Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Active Motif ChIP Sequencing Product Portfolio
- 6.11.5 Active Motif Recent Developments
7 North America
- 7.1 North America ChIP Sequencing Market Size (2021-2032)
- 7.2 North America ChIP Sequencing Market Size by Type
- 7.2.1 North America ChIP Sequencing Market Size by Type (2021-2026)
- 7.2.2 North America ChIP Sequencing Market Size by Type (2027-2032)
- 7.2.3 North America ChIP Sequencing Market Share by Type (2021-2032)
- 7.3 North America ChIP Sequencing Market Size by Application
- 7.3.1 North America ChIP Sequencing Market Size by Application (2021-2026)
- 7.3.2 North America ChIP Sequencing Market Size by Application (2027-2032)
- 7.3.3 North America ChIP Sequencing Market Share by Application (2021-2032)
- 7.4 North America ChIP Sequencing Market Size by Country
- 7.4.1 North America ChIP Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America ChIP Sequencing Market Size by Country (2021-2026)
- 7.4.3 North America ChIP Sequencing Market Size by Country (2027-2032)
- 7.4.4 North America ChIP Sequencing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe ChIP Sequencing Market Size (2021-2032)
- 8.2 Europe ChIP Sequencing Market Size by Type
- 8.2.1 Europe ChIP Sequencing Market Size by Type (2021-2026)
- 8.2.2 Europe ChIP Sequencing Market Size by Type (2027-2032)
- 8.2.3 Europe ChIP Sequencing Market Share by Type (2021-2032)
- 8.3 Europe ChIP Sequencing Market Size by Application
- 8.3.1 Europe ChIP Sequencing Market Size by Application (2021-2026)
- 8.3.2 Europe ChIP Sequencing Market Size by Application (2027-2032)
- 8.3.3 Europe ChIP Sequencing Market Share by Application (2021-2032)
- 8.4 Europe ChIP Sequencing Market Size by Country
- 8.4.1 Europe ChIP Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe ChIP Sequencing Market Size by Country (2021-2026)
- 8.4.3 Europe ChIP Sequencing Market Size by Country (2027-2032)
- 8.4.4 Europe ChIP Sequencing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China ChIP Sequencing Market Size (2021-2032)
- 9.2 China ChIP Sequencing Market Size by Type
- 9.2.1 China ChIP Sequencing Market Size by Type (2021-2026)
- 9.2.2 China ChIP Sequencing Market Size by Type (2027-2032)
- 9.2.3 China ChIP Sequencing Market Share by Type (2021-2032)
- 9.3 China ChIP Sequencing Market Size by Application
- 9.3.1 China ChIP Sequencing Market Size by Application (2021-2026)
- 9.3.2 China ChIP Sequencing Market Size by Application (2027-2032)
- 9.3.3 China ChIP Sequencing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia ChIP Sequencing Market Size (2021-2032)
- 10.2 Asia ChIP Sequencing Market Size by Type
- 10.2.1 Asia ChIP Sequencing Market Size by Type (2021-2026)
- 10.2.2 Asia ChIP Sequencing Market Size by Type (2027-2032)
- 10.2.3 Asia ChIP Sequencing Market Share by Type (2021-2032)
- 10.3 Asia ChIP Sequencing Market Size by Application
- 10.3.1 Asia ChIP Sequencing Market Size by Application (2021-2026)
- 10.3.2 Asia ChIP Sequencing Market Size by Application (2027-2032)
- 10.3.3 Asia ChIP Sequencing Market Share by Application (2021-2032)
- 10.4 Asia ChIP Sequencing Market Size by Country
- 10.4.1 Asia ChIP Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia ChIP Sequencing Market Size by Country (2021-2026)
- 10.4.3 Asia ChIP Sequencing Market Size by Country (2027-2032)
- 10.4.4 Asia ChIP Sequencing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa ChIP Sequencing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa ChIP Sequencing Market Size by Type
- 11.2.1 South America, Middle East & Africa ChIP Sequencing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa ChIP Sequencing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa ChIP Sequencing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa ChIP Sequencing Market Size by Application
- 11.3.1 South America, Middle East & Africa ChIP Sequencing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa ChIP Sequencing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa ChIP Sequencing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa ChIP Sequencing Market Size by Country
- 11.4.1 South America, Middle East & Africa ChIP Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa ChIP Sequencing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa ChIP Sequencing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa ChIP Sequencing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst